Loading...
Loading...
Savient Pharmaceuticals Inc
SVNT dipped 2.87% to $20.00 in the pre-market session. SVNT drug, Krystexxa, was approved by the Food and Drug Administration.
Crucell NV
CRXL lost 0.53% to $31.85 in the pre-market session.CRXL had announced its acquisition by Johnson & Johnson
JNJ.
Xilinx Inc
XLNX slipped 0.08% to $26.43 in the pre-market trading. XLNX demonstrated, at Intel Developer Forum, Intel QuickPath Technology for FPGAs.
Research In Motion Limited
RIMM fell 0.06% to $46.69 in the pre-market session.RIMM had reported strong Q2 earnings.
Read more
from Benzinga's Company news.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsTrading IdeasBenzinga’s Top Pre-Market NASDAQ LosersBiotechnologyCommunications EquipmentHealth CareInformation TechnologyPharmaceuticalsSemiconductors
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in